Seeing Is Believing

Currently out of the existing stock ratings of Jay Olson, 518 are a BUY (89.31%), 2 are a SELL (0.34%), 60 are a HOLD (10.34%).
Analyst Jay Olson, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 44.55% that have a potential upside of 40.99% achieved within 167 days.
Jay Olson’s has documented 1,162 price targets and ratings displayed on 72 stocks. The coverage is on Healthcare, Industrials, Financial Services, Utilities sectors.
Most recent stock forecast was given on INCY, yte at 30-Oct-2026.
Analyst best performing recommendations are on NKTR (NEKTAR THERAPEUTICS).
The best stock recommendation documented was for NKTR (NEKTAR THERAPEUTICS) at 11/7/2019. The price target of $300 was fulfilled within 1 day with a profit of $19.5 (6.95%) receiving and performance score of 69.52.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 22-Jun-2022
$38
$16.53 (76.99%)
$36
Buy Since 23-Jun-2025
$38
$16.53 (76.99%)
$36
Buy Since 28-Feb-2024
$35
$13.53 (63.02%)
$35
22 days ago
(19-Oct-2026)
9/16 (56.25%)
$15.2 (76.77%)
393
Buy Since 15-Dec-2025
$33
$11.53 (53.70%)
$37
1 months 16 days ago
(25-Sep-2026)
0/3 (0%)
$12.32 (59.57%)
Buy Since 17-Apr-2025
$34
$12.53 (58.36%)
$36
1 months 16 days ago
(25-Sep-2026)
4/6 (66.67%)
$13.32 (64.41%)
144
Which stock is Jay Olson most bullish on?
Which stock is Jay Olson most reserved on?
What Year was the first public recommendation made by Jay Olson?